JP2010510232A5 - - Google Patents

Download PDF

Info

Publication number
JP2010510232A5
JP2010510232A5 JP2009537331A JP2009537331A JP2010510232A5 JP 2010510232 A5 JP2010510232 A5 JP 2010510232A5 JP 2009537331 A JP2009537331 A JP 2009537331A JP 2009537331 A JP2009537331 A JP 2009537331A JP 2010510232 A5 JP2010510232 A5 JP 2010510232A5
Authority
JP
Japan
Prior art keywords
compound
compound according
chcl
chloro
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009537331A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010510232A (ja
JP5384358B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/084684 external-priority patent/WO2008064039A2/en
Publication of JP2010510232A publication Critical patent/JP2010510232A/ja
Publication of JP2010510232A5 publication Critical patent/JP2010510232A5/ja
Application granted granted Critical
Publication of JP5384358B2 publication Critical patent/JP5384358B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009537331A 2006-11-17 2007-11-14 眼圧降下剤であるプロスタグランジンプロドラッグ Expired - Fee Related JP5384358B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US86625006P 2006-11-17 2006-11-17
US60/866,250 2006-11-17
PCT/US2007/084684 WO2008064039A2 (en) 2006-11-17 2007-11-14 Prostaglandin prodrugs as ocular hypotensive agents

Publications (3)

Publication Number Publication Date
JP2010510232A JP2010510232A (ja) 2010-04-02
JP2010510232A5 true JP2010510232A5 (cg-RX-API-DMAC7.html) 2011-01-06
JP5384358B2 JP5384358B2 (ja) 2014-01-08

Family

ID=39276861

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009537331A Expired - Fee Related JP5384358B2 (ja) 2006-11-17 2007-11-14 眼圧降下剤であるプロスタグランジンプロドラッグ

Country Status (6)

Country Link
US (1) US7507817B2 (cg-RX-API-DMAC7.html)
EP (1) EP2094678B1 (cg-RX-API-DMAC7.html)
JP (1) JP5384358B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0719061A2 (cg-RX-API-DMAC7.html)
CA (1) CA2689293A1 (cg-RX-API-DMAC7.html)
WO (1) WO2008064039A2 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5532302B2 (ja) * 2006-07-10 2014-06-25 アラーガン インコーポレイテッド 治療化合物
ATE511506T1 (de) * 2007-01-22 2011-06-15 Allergan Inc Thiopen-derivate als wirkstoffe gegen okulare hypotonie
US7960379B2 (en) * 2008-03-14 2011-06-14 Allergan, Inc. Therapeutic compounds
US7705001B2 (en) * 2008-03-18 2010-04-27 Allergan, Inc Therapeutic substituted gamma lactams
WO2009132087A1 (en) * 2008-04-24 2009-10-29 Allergan, Inc. Thiophene derivatives useful as ocular hypotensive agents
US7803797B2 (en) * 2008-04-24 2010-09-28 Allergan, Inc. Substituted arylcyclopentenes as therapeutic agents
CN102076681A (zh) 2008-04-24 2011-05-25 阿勒根公司 作为治疗剂的取代γ-内酰胺
AU2009244513B2 (en) 2008-05-09 2014-04-10 Allergan, Inc. Therapeutic cyclopentane derivatives
US7981887B2 (en) 2008-05-09 2011-07-19 Allergan, Inc. Therapeutic compounds
US8569349B2 (en) 2008-05-09 2013-10-29 Allergan, Inc. Therapeutic compounds
CA2724605A1 (en) * 2008-05-27 2009-12-03 Allergan, Inc. Prostaglandin prodrugs as hypotensive agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4543353A (en) * 1981-11-27 1985-09-24 Farmitalia Carlo Erba S.P.A. Ester and amide derivatives of 13,14-didehydro prostaglandins
US5288754A (en) 1992-02-04 1994-02-22 Allergan, Inc. Polar C-1 esters of prostaglandins
BRPI0605926A2 (pt) 2005-01-14 2009-05-26 Allergan Inc ciclopentanos substituìdos ou ciclopentanonas como agentes terapêuticos

Similar Documents

Publication Publication Date Title
JP2010510232A5 (cg-RX-API-DMAC7.html)
JP2019104748A5 (cg-RX-API-DMAC7.html)
JP2012092103A5 (cg-RX-API-DMAC7.html)
JP2009543795A5 (cg-RX-API-DMAC7.html)
JP2013510885A5 (cg-RX-API-DMAC7.html)
JP2011037841A5 (cg-RX-API-DMAC7.html)
JP2010504286A5 (cg-RX-API-DMAC7.html)
JP2009539828A5 (cg-RX-API-DMAC7.html)
JP2007508359A5 (cg-RX-API-DMAC7.html)
JP2010536766A5 (cg-RX-API-DMAC7.html)
JP2010534247A5 (cg-RX-API-DMAC7.html)
JP2009537469A5 (cg-RX-API-DMAC7.html)
JP2013536235A5 (cg-RX-API-DMAC7.html)
JP2007534702A5 (cg-RX-API-DMAC7.html)
JP2009541340A5 (cg-RX-API-DMAC7.html)
JP2010536761A5 (cg-RX-API-DMAC7.html)
JP2013505929A5 (cg-RX-API-DMAC7.html)
JP2012502048A5 (cg-RX-API-DMAC7.html)
JP2015535847A5 (cg-RX-API-DMAC7.html)
JP2007519618A5 (cg-RX-API-DMAC7.html)
JP2009543792A5 (cg-RX-API-DMAC7.html)
JP2009543794A5 (cg-RX-API-DMAC7.html)
JP2009540009A5 (cg-RX-API-DMAC7.html)
JP2013515037A5 (cg-RX-API-DMAC7.html)
JP2010500416A5 (cg-RX-API-DMAC7.html)